Vor Biopharma
VOR
VOR
59 hedge funds and large institutions have $128M invested in Vor Biopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
17% less funds holding
Funds holding: 71 → 59 (-12)
32% less capital invested
Capital invested by funds: $188M → $128M (-$60.1M)
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
Holders
59
Holding in Top 10
3
Calls
$17K
Puts
$7K
Top Buyers
| 1 | +$133K | |
| 2 | +$72K | |
| 3 | +$65.3K | |
| 4 |
SG Americas Securities
New York
|
+$37K |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$36.8K |
Top Sellers
| 1 | -$345K | |
| 2 | -$286K | |
| 3 | -$228K | |
| 4 |
Millennium Management
New York
|
-$194K |
| 5 |
BlackRock
New York
|
-$123K |